Search Results
Jonathan A Ledermann – Maintenance Treatment for Recurrent Ovarian Carcinoma
Rucaparib maintenance for recurrent ovarian carcinoma
Dr. Ledermann on PARP Inhibitors in Maintenance Therapy for Ovarian Cancer
Dr. Ledermann on Rationale for ARIEL3 Trial in Ovarian Cancer
Prof Jonathan Ledermann
Rucaparib May Improve PFS in Patients With Ovarian Cancer
Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian Cancer
Dr. Ledermann on Systemic Treatment for Rare Gynecologic Tumors
Dr. Ledermann on Phase III ARIEL3 Results in Ovarian Cancer
Toxicities Associated With Rucaparib for the Treatment of Ovarian Cancer
Dr. Ledermann Discusses Olaparib in Ovarian Cancer
Rucaparib maintenance and monotherapy for ovarian cancer: trial updates
